Marshall Wace
ARKG icon

Marshall Wace’s ARK Genomic Revolution ETF ARKG Stock Holding History

Marshall Wace’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-118
Closed -$7K – 3320
2021
Q4 		$7K Buy
+118
New +$8.16K ﹤0.01% 3768
2021
Q1 		– Sell
-12,600
Closed -$1.18M – 2451
2020
Q4 		$1.18M Buy
+12,600
New +$1M 0.01% 1150

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Marshall Wace's ARKG Position: Q1 2022 in Review

Marshall Wace sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 118 shares — an estimated $7K sold.

Marshall Wace first reported a position in ARKG in Q4 2020 and held it in 2 quarters. The position peaked at $1.18M in Q4 2020. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

  • Marshall Wace reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
  • Marshall Wace sold 118 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $7K.
  • Marshall Wace first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 2 quarters.
  • Marshall Wace's ARK Genomic Revolution ETF position peaked at $1.18M in Q4 2020.
  • 387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.